Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic …

Intercept Pharmaceuticals to Collaborate With NIDDK on Study of Obeticholic Acid (INT-747) in Nonalcoholic …
Intercept Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic diseases, today announced the signing of a cooperative research and development agreement with the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to conduct a double blind, multi-center, study to …
Read more on PR Newswire via Yahoo! Finance

Hancock County’s jail equipped to handle drug withdrawal cases
Drug addicts say withdrawal is excruciating: Flu-like symptoms, extreme agitation and intense body ache.
Read more on The Findlay Courier

Protecting kids from poisons in the home
Ingesting chemicals isn’t the only concern.  Experts say how chemicals react with each other can cause dangers too.
Read more on KAIT Jonesboro